You Are Browsing ‘Health’ Category

Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) and Chimerix Inc. (NASDAQ:CMRX) Market-Run, Down to Ebola Trials: Meg Tirrell

by Paul Rados - on Oct 8th 2014 - No Comments

Tomahawk, WI 10/08/2014 (Basicsmedia) – The current Ebola epidemic which is believed to be the worst in history has pulled pharmaceutical companies together in the attempt of trying to find the ultimate solution in terms of cures and vaccines. Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) and other stocks in the space have experienced...

Sarepta Therapeutics Inc. (NASDAQ:SRPT) Surges Ahead on Ebola Cure with a 60%-80% Survival Rate Drug

by Cyrus Emen - on Oct 1st 2014 - No Comments

Tomahawk, WI 10/01/2014 (Basicsmedia) – Sarepta Therapeutics Inc. (NASDAQ:SRPT) is more than ready to provide its Ebola Drug if called upon by health officials. Appearing on an interview on CNBC, CEO, Chris Garabedian, reiterated that the company has enough stock to handle up to 100 cases at the moment. The announcement that Sarepta...

Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) Stock Responds Positively to FDA Approval for Expedited Ebola Trials

by Paul Young - on Sep 24th 2014 - No Comments

Tomahawk, WI 09/24/2014 (Basicsmedia) – Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) has announced that it will be participating in a consortium of clinical trials in West Africa as it seeks to bring the Ebola menace under control. CNBC’s Meg Tirrell reports that the FDA has approved the use of its drug in an expedited access...

Rite Aid Corporation (NYSE:RAD) Performing Poorly on Pharmaceutical Side of the Business: Jim Cramer

by Brian Campbell - on Sep 19th 2014 - No Comments

Tomahawk, WI 09/19/2014 (Basicsmedia) – Rite Aid Corporation (NYSE:RAD) pounding in the market in the recent past can be attributed to the company doing everything wrong, on the pharmaceutical side of the business. Despite sinking in the market by huge volumes, CNBC’s Jim Cramer believes the stock is still a strong buy with a huge...

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) Relying on Partnerships to Spur Growth

by Robert Miller - on Sep 18th 2014 - No Comments

Tomahawk, WI 09/18/2014 (Basicsmedia) – The biotech space remains the only performing industry at a time when the world economy is on a downward-trend, according to CNBC’s Jim Cramer.  ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) remains a top pick for the ‘Mad Money’ analyst as a pioneer of antisense technology, which is...

Orexigen Therapeutics, Inc. (NASDAQ:OREX) Obesity Pill Approval Fails to Spark Momentum in the Market

by Cyrus Emen - on Sep 15th 2014 - No Comments

Tomahawk, WI 09/15/2014 (Basicsmedia) – Patients suffering from obesity can finally heave a sigh of relief after the Food and Drug’s administration approved Orexigen Therapeutics, Inc. (NASDAQ:OREX)’s obesity drug, Contrave. Contrary to expectations, the approval did not result in an uplift on the company’s stock in the market,...

Orexigen Therapeutics, Inc. (NASDAQ:OREX) Stock Sinks Despite FDA Approval for Obesity Pill

by Kenneth Hall - on Sep 12th 2014 - No Comments

Tomahawk, WI 09/12/2014 (Basicsmedia) – Orexigen Therapeutics, Inc. (NASDAQ:OREX) stock sunk in Thursday trading session by highs of 10.51%, despite the company gaining approval for Contrave, a weight-loss contraceptive pill. The drop according to CNBC’s Meg Tirrell could in some way be attributed to the company announcing it was...

Top Three IrresistibleBiotech Stocks: Biogen Idec Inc. (NASDAQ:BIIB) Celgene Corporation (NASDAQ:CELG) and Gilead Sciences, Inc. (NASDAQ:GILD)

by Paul Young - on Sep 8th 2014 - No Comments

Tomahawk, WI 09/08/2014 (Basicsmedia) – Biogen Idec Inc. (NASDAQ:BIIB), Celgene Corporation (NASDAQ:CELG) and Gilead Sciences, Inc. (NASDAQ:GILD) remainthe top three irresistible stock picks, on the broader biotech space according to John Schroer of Allianz Global Investors. In an interview on CNBC, Schroer reiterated that Biogen has...

Jim Cramer’s High Momentum Stocks: Tesla Motors Inc. (NASDAQ:TSLA), Netflix, Inc. (NASDAQ:NFLX), Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

by Brian Campbell - on Sep 5th 2014 - No Comments

Tomahawk, WI 09/05/2014 (Basicsmedia) – Tesla Motors Inc. (NASDAQ:TSLA), Netflix, Inc. (NASDAQ:NFLX) Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) remain CNBC’s ‘Mad Money’ analyst, Jim Cramer, top picks, when in pursue of high momentum in the market.  Tesla Motors Inc. (NASDAQ:TSLA) has enjoyed an impressive run in the market,...

GlaxoSmithKline plc (ADR) (NYSE:GSK) and NIH Spearheading Development of Ebola Vaccine

by Jason Gonzalez - on Sep 2nd 2014 - No Comments

Tomahawk, WI 09/02/2014 (Basicsmedia) – Dubbed as the most severe and deadly outbreak, the Ebola menace in West Africa has caught the attention of GlaxoSmithKline plc (ADR) (NYSE:GSK) and National institute of health. CNBC’s Meg Tirrell reports that NIH and GlaxoSmithKline have partnered to develop a vaccine that is said to have had...